Catherine S. Spina

Catherine S. Spina

Auto-generated profile, based on publicly available information

Catherine S. Spina

Columbia University Medical Center, New York, NY

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JMJosé Ruben Morones-Ramírez
José Ruben Morones-Ramírez
JWJonathan A. Winkler
Jonathan A. Winkler
CSCatherine S. Spina
Catherine S. Spina
JCJames J. Collins
James J. Collins
Silver enhances the activity of a wide range of antibiotics and broadens the spectrum of vancomycin, rendering it effective against Gram-negative bacteria.

9 June 2013 in Nature
Verified
Journal Article
Open access
PDF file
SMSheetal R. Modi
Sheetal R. Modi
HLHenry H. Lee
Henry H. Lee
CSCatherine S. Spina
Catherine S. Spina
JCJames J. Collins
James J. Collins
By exploring the phageome in mice, antibiotic treatment is shown to lead to enrichment of phage-encoded genes that are related to antibiotic resistance. Phages naturally coexist in abundance with their bacterial hosts in the mammalian gut. Antibiotic treatment can negatively affect the gut environment and cause immune and metabolic deficiencies. Previously the disruption of intestinal homeostasis has been studied mainly at the level of bacterial species, but here James Collins and colleagues use comparative metagenomics to profile gut phage populations following antibiotic treatment in mice. They find that exposure to ciprofloxacin or ampicillin enriches phage-encoded genes related to antibiotic resistance. Furthermore, phages from antibiotic-treated mice are able to increase resistance in an aerobically cultured naive microbiota. These results suggest that antibiotic treatment increases the frequency of phage integration and stimulates broad host range, which promotes a functional reservoir that is both genetically diverse and highly accessible to gut bacteria. The mammalian gut ecosystem has considerable influence on host physiology1,2,3,4, but the mechanisms that sustain this complex environment in the face of different stresses remain obscure. Perturbations to the gut ecosystem, such as through antibiotic treatment or diet, are at present interpreted at the level of bacterial phylogeny5,6,7. Less is known about the contributions of the abundant population of phages to this ecological network. Here we explore the phageome as a potential genetic reservoir for bacterial adaptation by sequencing murine faecal phage populations following antibiotic perturbation. We show that antibiotic treatment leads to the enrichment of phage-encoded genes that confer resistance via disparate mechanisms to the administered drug, as well as genes that confer resistance to antibiotics unrelated to the administered drug, and we demonstrate experimentally that phages from treated mice provide aerobically cultured naive microbiota with increased resistance. Systems-wide analyses uncovered post-treatment phage-encoded processes related to host colonization and growth adaptation, indicating that the phageome becomes broadly enriched for functionally beneficial genes under stress-related conditions. We also show that antibiotic treatment expands the interactions between phage and bacterial species, leading to a more highly connected phage–bacterial network for gene exchange. Our work implicates the phageome in the emergence of multidrug resistance, and indicates that the adaptive capacity of the phageome may represent a community-based mechanism for protecting the gut microflora, preserving its functional robustness during antibiotic stress.

3 July 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SKSameer Kalghatgi
Sameer Kalghatgi
CSCatherine S. Spina
Catherine S. Spina
JCJames Costello
James Costello
Marc LiesaMarc Liesa
Marc Liesa
JMJosé Ruben Morones-Ramírez
José Ruben Morones-Ramírez
JCJames J. Collins
James J. Collins
Prolonged antibiotic treatment can lead to detrimental side effects in patients, including ototoxicity, nephrotoxicity, and tendinopathy, yet the mechanisms underlying the effects of antibiotics in mammalian systems remain unclear. It has been suggested that bactericidal antibiotics induce the formation of toxic reactive oxygen species (ROS) in bacteria. We show that clinically relevant doses of bactericidal antibiotics—quinolones, aminoglycosides, and β-lactams—cause mitochondrial dysfunction and ROS overproduction in mammalian cells. We demonstrate that these bactericidal antibiotic–induced effects lead to oxidative damage to DNA, proteins, and membrane lipids. Mice treated with bactericidal antibiotics exhibited elevated oxidative stress markers in the blood, oxidative tissue damage, and up-regulated expression of key genes involved in antioxidant defense mechanisms, which points to the potential physiological relevance of these antibiotic effects. The deleterious effects of bactericidal antibiotics were alleviated in cell culture and in mice by the administration of the antioxidant N-acetyl-l-cysteine or prevented by preferential use of bacteriostatic antibiotics. This work highlights the role of antibiotics in the production of oxidative tissue damage in mammalian cells and presents strategies to mitigate or prevent the resulting damage, with the goal of improving the safety of antibiotic treatment in people.

6 January 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
MBMark P Brynildsen
Mark P Brynildsen
JWJonathan A Winkler
Jonathan A Winkler
CSCatherine S Spina
Catherine S Spina
IMI Cody MacDonald
I Cody MacDonald
JCJames J Collins
James J Collins
The first global metabolic models that incorporate reactive oxygen species in E. coli reveal targets for potentiating the action of antibacterials. The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis1. Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS)2,3,4, we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.

4 May 2014 in Nature Methods
Verified
Journal Article
Closed access
YTYu-suke Torisawa
Yu-suke Torisawa
CSCatherine S Spina
Catherine S Spina
TMTadanori Mammoto
Tadanori Mammoto
AMAkiko Mammoto
Akiko Mammoto
JWJames C Weaver
James C Weaver
DIDonald E Ingber
Donald E Ingber

14 April 2014 in Genes & Development
Verified
Journal Article
Open access
PDF file
AUAchia Urbach
Achia Urbach
AYAlena Yermalovich
Alena Yermalovich
JZJin Zhang
Jin Zhang
CSCatherine S. Spina
Catherine S. Spina
HZHao Zhu
Hao Zhu
GDGeorge Q. Daley
George Q. Daley
Wilms Tumor, the most common pediatric kidney cancer, evolves from the failure of terminal differentiation of the embryonic kidney. Here we show that overexpression of the heterochronic regulator Lin28 during kidney development in mice markedly expands nephrogenic progenitors by blocking their final wave of differentiation, ultimately resulting in a pathology highly reminiscent of Wilms tumor. Using lineage-specific promoters to target Lin28 to specific cell types, we observed Wilms tumor only when Lin28 is aberrantly expressed in multiple derivatives of the intermediate mesoderm, implicating the cell of origin as a multipotential renal progenitor. We show that withdrawal of Lin28 expression reverts tumorigenesis and markedly expands the numbers of glomerulus-like structures and that tumor formation is suppressed by enforced expression of Let-7 microRNA. Finally, we demonstrate overexpression of the LIN28B paralog in a significant percentage of human Wilms tumor. Our data thus implicate the Lin28/Let-7 pathway in kidney development and tumorigenesis.